538965 — CONCORD DRUGS Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹642.10m
- IN₹831.07m
- IN₹452.45m
- 30
- 24
- 85
- 43
Annual cashflow statement for CONCORD DRUGS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 42.9 | 22.5 | 12.5 | 6.29 | 6.91 |
| Depreciation | |||||
| Non-Cash Items | 12.4 | 14 | 16.3 | 18.6 | 20.1 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -52.8 | -46.4 | -28.4 | -32.5 | -4.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 16.2 | 7.74 | 16.6 | 7.92 | 37.2 |
| Capital Expenditures | -36.7 | -0 | -8.57 | -10.2 | -23.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.081 | 0.123 | -14.1 | 0.093 | 0.145 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -36.7 | 0.122 | -22.7 | -10.1 | -23.2 |
| Financing Cash Flow Items | -13.3 | -17.8 | -10.7 | -8.58 | -20.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.7 | 16.8 | 6.24 | 2.83 | -14.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.234 | 24.7 | 0.215 | 0.67 | -0.245 |